Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023
Current assets
Cash and equivalents	$ 3,588	$ 8,051
Receivables, less allowances of $100 in 2023 and $121 in 2024	2,927	2,518
Inventories	2,180	2,006
Other current assets	1,497	1,244
Total current assets	10,192	13,819
Property, plant and equipment, net	2,807	2,363
Other assets
Goodwill	18,067	14,480
Other intangible assets	10,436	6,263
Copeland note receivable and equity investment held-for-sale	0	3,255
Other	2,744	2,566
Total other assets	31,247	26,564
Total assets	44,246	42,746
Current liabilities
Short-term borrowings and current maturities of long-term debt	532	547
Accounts payable	1,335	1,275
Accrued expenses	3,875	3,210
Total current liabilities	5,742	5,032
Long-term debt	7,155	7,610
Other liabilities	3,840	3,506
Equity
Common stock, $0.50 par value; authorized, 1,200.0 shares; issued, 953.4 shares; outstanding, 572.0 shares in 2023; 570.2 shares in 2024	477	477
Additional paid-in-capital	169	62
Retained earnings	40,830	40,070
Accumulated other comprehensive income (loss)	(868)	(1,253)
Cost of common stock in treasury, 381.4 shares in 2023; 383.2 shares in 2024	(18,972)	(18,667)
Common stockholders’ equity	21,636	20,689
Noncontrolling interests in subsidiaries	5,873	5,909
Total equity	27,509	26,598
Total liabilities and equity	$ 44,246	$ 42,746

Equity Method Investments And Financing Receivable, After Allowance For Credit Loss

No definition available.

Name:	emr_EquityMethodInvestmentsAndFinancingReceivableAfterAllowanceForCreditLoss
Namespace Prefix:	emr_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).